ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Is Sp Cd Sector

Is Sp Cd Sector (IUCD)

12.575
0.075
(0.60%)
Closed June 26 10:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
12.575
Bid
12.575
Ask
12.59
Volume
150,900
12.4175 Day's Range 12.59
0.00 52 Week Range 0.00
Previous Close
12.50
Open
12.485
Last Trade Time
Average Volume (3m)
-
Financial Volume
US$ 1,892,150
VWAP
12.5391

IUCD Latest News

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 26 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 25-Jun-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 25 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 24-Jun-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 24 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 21-Jun-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 21 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 20-Jun-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 20 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 19-Jun-24 NAV PER SHARE: Fund Holiday     Fund...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 19 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 18-Jun-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 18 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 17-Jun-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Con Dis Sec $ Acc Net Asset Value(s)

iShares V S&P 500 Con Dis Sec $ Acc 17 June 2024   FUND: iShares S&P 500 Consumer Discretionary Sector UCITS ETF USD (Acc) DEALING DATE: 14-Jun-24 NAV PER SHARE: Official NAV USD...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DNDelta 9 Cannabis Inc
$ 0.015
(50.00%)
411.77k
SCYScandium International Mining Corp
$ 0.02
(33.33%)
12k
FANSFansUnite Entertainment Inc
$ 0.045
(28.57%)
642.14k
THTheratechnologies Inc
$ 2.14
(20.22%)
77.34k
BCTBriaCell Therapeutics Corp
$ 1.53
(17.69%)
13.66k
NCFNorthcliff Resources Ltd
$ 0.02
(-20.00%)
39k
AMMAlmaden Minerals Ltd New
$ 0.085
(-19.05%)
3.24k
IVQInvesque Inc
$ 0.145
(-14.71%)
101.2k
LPENLoop Energy Inc
$ 0.03
(-14.29%)
55k
ASNDAscendant Resources Inc
$ 0.035
(-12.50%)
11k
TRPTC Energy Corporation
$ 52.80
(-1.31%)
13.61M
CNQCanadian Natural Resources Ltd
$ 48.35
(-0.04%)
11.93M
TTelus Corp
$ 20.80
(-1.89%)
6.72M
POWPower Corp of Canada
$ 38.32
(0.31%)
6.58M
FCUFission Uranium Corp
$ 1.18
(-0.84%)
5.61M

Discussion

View Full Feed
stock1ace1 stock1ace1 4 minutes ago
*** VRNA Halted $14.60 Fda approval -> Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
VRNA
RobotDroid RobotDroid 5 minutes ago
They won't.
NWBO
PickStocks PickStocks 5 minutes ago
Doreen is a friend of yours…….lol
COOP
docsetc docsetc 5 minutes ago
Please be aware, ENZC has NO biotech to speak of at this moment. Zhabilov's ITV-1 failed toxicology tests and has been tossed into the back freezer as a shelf decoration. IPF-Immune also does not work. Clone3 and Clone7, and all other monoclonal antibody research material is over parked at the
ENZC
DewDiligence DewDiligence 5 minutes ago
CLF’s press conference today with Sen. Brown and USW President (29 minutes):

[yt]02pyWqyClFQ[/yt]
CLF
sprenkld sprenkld 5 minutes ago
From your mouth to the Stock God's ears...lolol.
SAPX
sprenkld sprenkld 5 minutes ago
From your mouth to the Stock God's ears...lolol.
SAPX
FCF2020 FCF2020 5 minutes ago
Tom Nash(CEO) is a total f up. Don't think anyone wants advice on how to bring their business to the bottom. Disruptive fintech? Nope.
XALL
Goulet57 Goulet57 5 minutes ago
On any and all of these message boards where people spend endless hours in their mothers’ basements trashing companies, you gotta ask yourself in each and every case, . . . why are they even here? There has to be good reason to drag them away from reruns of Gilligan’s Island and Dukes of Hazzard.
PPCB
monocle monocle 6 minutes ago
Due for green I guess, last was June 11th.

2 green days all of June in fact, 13 days red.

Without news, green tomorrow doesn't mean a whole lot.
NB
VeronicaFox VeronicaFox 6 minutes ago
Totally disagree, but It’s funny watching you trying to fit your entire vocabulary into one sentence.

$126 total volume.
KEGS
CatfishHunter CatfishHunter 6 minutes ago
Given the hand holding with FDA during this process and Mayo ramping up, I’m 95%+ confident in approval. No worries.
RDGL
Margin Buu Margin Buu 6 minutes ago
The timing of the approval announcement is in the hands of the regulators. Correct, and I’m fully expecting to see them approve DCVax-L any time within the next several weeks. 😎 No worries.
NWBO
SF971 SF971 6 minutes ago
Stocks like GTVH often see the biggest gains in pennyland, because they will say/do anything to attract interest.

The financier will make money for themselves and early investors.

Just remember, TK can't convert and sell and pay down the $4.6 M+ convertible debt unless
GTVH
mouton29 mouton29 7 minutes ago
Re: Eyepoint
the logic in quote i gave above is bizarre. It’s a stretch to say having 2 different dose arms mean that sham is ok?

FWIW (and that isn't much), I note that the sham injections in the Eyepoint phase 3 are of the type that this article (https://www.ncbi.nlm.nih.gov/
georgejjl georgejjl 7 minutes ago
Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study

"...Overall, 154 participants were enrolled and treated with trofinetide in LILAC. The most common adverse events in LILAC were diarrhea (74.7%), vomiting (28.6%), and COVID-19 (11.0%). D
AVXL
Denisk Denisk 7 minutes ago
why do you say$0.7218. I see $0.6982..
AMRN
IceCold8 IceCold8 7 minutes ago
Considering an r/s has occurred already with no result with the exception of the pps going down,what are the odds we have another reverse split?
AGSS
Carjockey2 Carjockey2 9 minutes ago
Boom

.50 AH
FFIE
quester614 quester614 9 minutes ago
I gave up counting the bags I carry. The risk reward in the OTC is worth the gamble. You play with the understanding you could LOSE everything. Which I have many times. BCJ I remember when I first stayed here posting what I thought about this SCAM. You condemn me then and still think I'm here to rai
XERI
WebSlinger WebSlinger 9 minutes ago
>

KBLB isn't anywhere near revenue.

The last PR said that they are breeding eggs in the next couple of months, and then will probably take a break because of "suboptimal rearing conditions".

No revenue in 2024 means more
KBLB
BurgerKing82 BurgerKing82 9 minutes ago
Yea,I wish I got in at 8 or 9
NNAX
lockstock31 lockstock31 9 minutes ago
Just ignore my posts. Age is catching up with me!
GTVH

Your Recent History

Delayed Upgrade Clock